Vikas Srinivasan Sridhar

Research

Acetazolamide Albuminuria Chronic Kidney Disease Glomerular Filtration Rate Sglt2 Inhibitor Type 2 Diabetes

Latest papers

The Case | Severe symptomatic hypocalcemia in a patient with sickle cell disease.
Kidney international · 2019
Renal SGLT mRNA expression in human health and disease: a study in two cohorts.
American journal of physiology. Renal physiology · 2019 · first author
Variation of High-Sensitivity Troponin T Results in Patients Undergoing Continuous Renal Replacement Therapy.
Canadian journal of kidney health and disease · 2019 · first author

All 3 publications

Latest funding

Adding AcetazolamIde on top of SGLT2 inhibition in Type 2 Diabetes and Albuminuria ('DIPPER') Study
CIHR · 2026 · Principal investigator
$761,176
SodiUm Glucose co-trAnspoRt-2 inhibitioN diabeteS And and kidney function Loss in Type 1 diabetes: The "SUGARNSALT" Team Grant Program
CIHR · 2021 · Co-investigator
$992,774

All 2 grants and awards

3 publications.

01

The Case | Severe symptomatic hypocalcemia in a patient with sickle cell disease.

Gregoire P, Srinivasan Sridhar V, Josse RG, Reich HN

Kidney international2019

DOI: 10.1016/j.kint.2019.05.013 PMID: 31759495

02

Renal SGLT mRNA expression in human health and disease: a study in two cohorts.

Srinivasan Sridhar V, Ambinathan JPN, Kretzler M, Pyle LL, Bjornstad P, Eddy S, Cherney DZ, Reich HN, European Renal cDNA Bank (ERCB);, Nephrotic Syndrome Study Network (NEPTUNE)

American journal of physiology. Renal physiology2019First author

DOI: 10.1152/ajprenal.00370.2019 PMID: 31545924

03

Variation of High-Sensitivity Troponin T Results in Patients Undergoing Continuous Renal Replacement Therapy.

Srinivasan Sridhar V, Chen M, Gerson H, MacNamara E, Nessim SJ

Canadian journal of kidney health and disease2019First author

DOI: 10.1177/2054358119828386 PMID: 30800332

Adding AcetazolamIde on top of SGLT2 inhibition in Type 2 Diabetes and Albuminuria ('DIPPER') Study

Principal investigatorCIHR2026Project Grant

Principal investigators: Cherney, David Z; Connelly, Kim A; Levin, Adeera; Odutayo, Ayodele; Perkins, Bruce A; Srinivasan Sridhar, Vikas

Keywords: Acetazolamide; Albuminuria; Chronic Kidney Disease; Glomerular Filtration Rate; Sglt2 Inhibitor; Type 2 Diabetes

$761,176

SodiUm Glucose co-trAnspoRt-2 inhibitioN diabeteS And and kidney function Loss in Type 1 diabetes: The "SUGARNSALT" Team Grant Program

Co-investigatorCIHR2021Team Grant: DM/TS - CIHR-KFOC - Diabetic Kidney Disease

Principal investigators: Cherney, David Z; Campbell, David J; Layton, Anita; Perkins, Bruce A

Keywords: Albuminuria; Biological Sex; Blood Pressure; Cardiovascular Disease; Diabetes; Gfr Slope; Glycemic Control; Kidney Health And Disease; Patient Oriented Research; Sglt2 Inhibition

$992,774

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2026

Subject: Prospective PhD student: Acetazolamide Dear Professor Srinivasan Sridhar, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "The Case | Severe symptomatic hypocalcemia in a patient with sickle cell disease." (2019), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Adding AcetazolamIde on top of SGLT2 inhibition in Type 2 Diabetes and Albuminuria ('DIPPER') Study" (2026), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]